IFNG and neoplasm: In 2017, Kim et al. found that OMVs from E. coli could effectively induce interferon-γ (IFNγ)-mediated long-term anti-tumor immune responses28, however, their study did not utilize OMVs decorated with tumor antigens to stimulate antigen-specific anti-tumor immunity, as the technology to accomplish this had not yet been developed.